T cells mediating an immune response and methods of use
CA 2242590 A1 · Owner: Parmiani, Giorgio · Inventors: Parmiani, Giorgio; Berd, David; Sensi, Marialuisa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to T cells compositions, and methos of , obtaining and using the same including and not limited to methods of treating cancer. The methods of the present invention include inter alia: a method of generating T cells capable of infiltrating a tumor of a human and participating in an immune response against the tumor; and a method of treating cancer comprising administering to a human afflicted with a tumor a therapeutically effective amount of T cells that mediate tumor regression the , T cells having been either isolated from the tumor of the human after immunization of the human with a composition comprising hapten-modified tumor cells and/or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.